Because baicalein significantly activates the ATM/CHK2/CDC25C signaling axis, which may lead to G2/M arrest, we next determined whether blocking CHK2 could attenuate baicalein-induced G2/M arrest to confirm the role of CHK2 activation in baicalein-mediated G2/M arrest in ovarian cancer cells. This evidence concerns the gene CHEK2 and ovarian cancer.